-
CTSO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Cytosorbents (CTSO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 12.17 mm | 12.17 mm | 12.17 mm | 12.17 mm | 12.17 mm | 12.17 mm |
Cash burn (monthly) | 924.46 k | (no burn) | 1.47 mm | 2.03 mm | 820.41 k | 1.54 mm |
Cash used (since last report) | 4.20 mm | n/a | 6.65 mm | 9.19 mm | 3.72 mm | 6.99 mm |
Cash remaining | 7.97 mm | n/a | 5.52 mm | 2.98 mm | 8.45 mm | 5.17 mm |
Runway (months of cash) | 8.6 | n/a | 3.8 | 1.5 | 10.3 | 3.4 |
13F holders | Current |
---|---|
Total holders | 35 |
Opened positions | 6 |
Closed positions | 21 |
Increased positions | 4 |
Reduced positions | 7 |
13F shares | Current |
---|---|
Total value | 13.66 bn |
Total shares | 9.11 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Skylands Capital | 2.76 mm | $4.13 bn |
Vanguard | 1.95 mm | $2.92 bn |
Sargent Investment | 1.63 mm | $2.44 bn |
CM Management | 800.00 k | $1.20 bn |
BlackRock | 627.30 k | $940.96 mm |
Geode Capital Management | 467.06 k | $700.73 mm |
CIBC Private Wealth | 172.65 k | $258.97 mm |
Advisor | 122.42 k | $183.63 mm |
AMH Equity | 82.80 k | $124.20 mm |
Renaissance Technologies | 79.62 k | $119.43 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Jan 25 | Mariani Peter J | Common Stock | Acquire X | No | No | 1 | 32,625 | 32.63 k | 433,988 | |
17 Jan 25 | Mariani Peter J | Series B Right Warrants Common Stock | Other | Acquire J | No | No | 0 | 32,625 | 0.00 | 32,625 |
17 Jan 25 | Mariani Peter J | Series A Right Warrants Common Stock | Other | Acquire J | No | No | 0 | 32,625 | 0.00 | 32,625 |
17 Jan 25 | Mariani Peter J | Subscription Rights Common Stock | Dispose X | No | No | 1 | 32,625 | 32.63 k | 0 | |
17 Jan 25 | Phillip P. Chan | Common Stock | Acquire X | No | No | 1 | 90,832 | 90.83 k | 1,243,195 | |
17 Jan 25 | Phillip P. Chan | Series B Right Warrants Common Stock | Other | Acquire J | No | No | 0 | 90,832 | 0.00 | 90,832 |
17 Jan 25 | Phillip P. Chan | Series A Right Warrants Common Stock | Other | Acquire J | No | No | 0 | 90,832 | 0.00 | 90,832 |
17 Jan 25 | Phillip P. Chan | Subscription Rights Common Stock | Dispose X | No | No | 1 | 90,832 | 90.83 k | 0 | |
17 Jan 25 | Alan D. Sobel | Common Stock | Acquire X | No | No | 1 | 21,950 | 21.95 k | 123,807 | |
17 Jan 25 | Alan D. Sobel | Series B Right Warrants Common Stock | Other | Acquire J | No | No | 0 | 21,950 | 0.00 | 21,950 |